Back to Research Hub
Xenon Pharmaceuticals Inc.
XENE
$52.79+1.58 (+3.09%)
Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada.
StreetsValue research for Xenon Pharmaceuticals Inc. (XENE)
Members get the full report for Xenon Pharmaceuticals Inc.: a fair value estimate and valuation analysis, economic moat rating, growth and profitability factor grades, a bull and bear investment thesis, analyst price targets, insider and congressional trading activity, and which super investors own the stock.